Equine Infectious Anemia Virus Cellular Partners Along the Viral Cycle
Open Access
Abstract
Equine infectious anemia virus (EIAV) is the simplest described lentivirus within the Retroviridae family, related to the human immunodeficiency viruses (HIV-1 and HIV-2). There is an important interplay between host cells and viruses. Viruses need to hijack cellular proteins for their viral cycle completion and some cellular proteins are antiviral agents interfering with viral replication. HIV cellular partners have been extensively studied and described, with a special attention to host proteins able to inhibit specific steps of the viral cycle, called restriction factors. Viruses develop countermeasures against these restriction factors. Here, we aim to describe host cellular protein partners of EIAV viral replication, being proviral or antiviral. A comprehensive vision of the interactions between the virus and specific host’s proteins can help with the discovery of new targets for the design of therapeutics. Studies performed on HIV-1 can provide insights into the functioning of EIAV, as well as differences, as both types of virus research can benefit from each other.Keywords
Funding Information
- French Agency for Food, Environmental and Occupational Health & Safety (ANSES) (21E1168/00061963)
- Normandy Region RIN Recherche 2020—Chaire d’excellence (21E1168/00061963)
This publication has 93 references indexed in Scilit:
- Host ZCCHC3 blocks HIV-1 infection and production through a dual mechanismiScience, 2024
- Retroviral integration: Site mattersBioEssays, 2015
- Inhibition of virus replication and induction of human tetherin gene expression by equine IFN-α1Veterinary Immunology and Immunopathology, 2013
- Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1Virology, 2013
- Comparative requirements for the restriction of retrovirus infection by TRIM5α and TRIMCypVirology, 2007
- Antiretroviral potential of human tripartite motif-5 and related proteinsVirology, 2006
- The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in poniesVirology, 2006
- cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicingVirology, 2004
- An In Vitro Transcription System that Recapitulates Equine Infectious Anemia Virus Tat-Mediated Inhibition of Human Immunodeficiency Virus Type 1 Tat Activity Demonstrates a Role for Positive Transcription Elongation Factor b and Associated Proteins in the Mechanism of Tat ActivationVirology, 2000
- The specificity of the HIV-1 proteasePerspectives in Drug Discovery and Design, 1993